bioMérieux is a French multinational company that operates in the in vitro diagnostics sector. The company was founded in 1963 by Alain Mérieux and is headquartered in Marcy-l'Étoile, France. bioMérieux is a leader in the field of microbiology and offers a wide range of diagnostic solutions for clinical laboratories, industrial microbiology, and food safety.

In recent years, bioMérieux has made a commitment to decarbonisation and reducing its carbon footprint. The company has implemented a number of initiatives to reduce its energy consumption and increase its use of renewable energy sources.

One of the key initiatives that bioMérieux has undertaken is the implementation of a corporate energy strategy. This strategy involves the development of energy efficiency measures, the use of renewable energy sources, and the implementation of a carbon management system. The goal of this strategy is to reduce the company's energy consumption and greenhouse gas emissions.

As part of its corporate energy strategy, bioMérieux has also implemented a corporate power purchase agreement (PPA). This agreement allows the company to purchase renewable energy directly from a wind farm in France. By purchasing renewable energy directly, bioMérieux is able to reduce its carbon footprint and support the development of renewable energy sources.

In addition to its corporate PPA, bioMérieux has also invested in renewable energy projects. The company has installed solar panels at its facilities in France and has also invested in a wind farm in Mexico. These investments in renewable energy help to reduce the company's reliance on fossil fuels and support the transition to a low-carbon economy.

Another key initiative that bioMérieux has undertaken is the implementation of an energy management system. This system allows the company to monitor its energy consumption and identify opportunities for energy savings. By implementing energy efficiency measures, bioMérieux is able to reduce its energy consumption and greenhouse gas emissions.

In addition to its energy management system, bioMérieux has also implemented a carbon management system. This system allows the company to track its greenhouse gas emissions and identify opportunities for emissions reductions. By implementing emissions reduction measures, bioMérieux is able to reduce its carbon footprint and contribute to the fight against climate change.

Overall, bioMérieux's commitment to decarbonisation and reducing its carbon footprint is an important step towards a more sustainable future. By implementing energy efficiency measures, investing in renewable energy, and implementing carbon management systems, bioMérieux is setting an example for other companies in the in vitro diagnostics sector to follow.